In this interview Jean-Simon Diallo, CEO and Scientific Founder, and JonDavid De Jong, VP Scientific Operations discuss the challenges antiviral defenses pose to the successful production of vaccines and advanced therapies and what Virica is doing to tackle this problem.

Check out the interview with BioInsights here!

Read full interview:  Virica’s BioInsights Interview